MEDICINA
Departamento
University of Naples Federico II
Nápoles, ItaliaPublicaciones en colaboración con investigadores/as de University of Naples Federico II (23)
2023
-
Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry
European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 9, Núm. 1, pp. 42-53
2022
-
Outcome of liver cancer patients with SARS-CoV-2 infection: An International, Multicentre, Cohort Study
Liver International, Vol. 42, Núm. 8, pp. 1891-1901
2021
-
A generic emergency protocol for patients with inborn errors of metabolism causing fasting intolerance: A retrospective, single-center study and the generation of www.emergencyprotocol.net
Journal of Inherited Metabolic Disease, Vol. 44, Núm. 5, pp. 1124-1135
-
Clinical Risk Prediction in Patients With Left Ventricular Myocardial Noncompaction
Journal of the American College of Cardiology, Vol. 78, Núm. 7, pp. 643-662
-
Strategy to prevent epitope masking in CAR.CD19+ B-cell leukemia blasts
Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 6
2019
-
Allogeneic stem cell transplantation for acquired pure red cell aplasia
American Journal of Hematology
-
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
European Journal of Immunology, Vol. 49, Núm. 10, pp. 1457-1973
2018
-
The Cardiomyopathy Registry of the EURObservational Research Programme of the European Society of Cardiology: Baseline data and contemporary management of adult patients with cardiomyopathies
European Heart Journal, Vol. 39, Núm. 20, pp. 1784-1793
2017
-
Does renal function affect the efficacy or safety of a pharmacoinvasive strategy in patients with ST-elevation myocardial infarction? A meta-analysis
American Heart Journal, Vol. 193, pp. 46-54
-
Outcome of lower-risk patients with myelodysplastic syndromes without 5q deletion after failure of erythropoiesis-stimulating agents
Journal of Clinical Oncology, Vol. 35, Núm. 14, pp. 1591-1597
2015
-
Consistency of benefit from an early invasive strategy after fibrinolysis: A patient-level meta-analysis
Heart, Vol. 101, Núm. 19, pp. 1554-1561
-
Relationship between time to invasive assessment and clinical outcomes of patients undergoing an early invasive strategy after fibrinolysis for ST-segment elevation myocardial infarction: A patient-level analysis of the randomized early routine invasive clinical trials
JACC: Cardiovascular Interventions, Vol. 8, Núm. 1, pp. 166-174
2014
-
Research update for articles published in EJCI in 2012
European Journal of Clinical Investigation, Vol. 44, Núm. 10, pp. 1010-1023
-
Routine invasive management early after fibrinolysis: Relationship between baseline risk and treatment effects in a pooled patient-level analysis of 7 randomized controlled trials
American Heart Journal, Vol. 168, Núm. 5, pp. 757-765.e3
2013
-
Common susceptibility alleles and SQSTM1 mutations predict disease extent and severity in a multinational study of patients with Paget's disease
Journal of Bone and Mineral Research, Vol. 28, Núm. 11, pp. 2338-2346
2012
-
Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: A consensus proposal
International Archives of Allergy and Immunology, Vol. 157, Núm. 3, pp. 215-225
-
European Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and future perspectives
Wiener Klinische Wochenschrift, Vol. 124, Núm. 23-24, pp. 807-814
2011
-
Endogenous cardiac stem cell activation by insulin-like growth factor-1/hepatocyte growth factor intracoronary injection fosters survival and regeneration of the infarcted pig heart
Journal of the American College of Cardiology, Vol. 58, Núm. 9, pp. 977-986
-
Genome-wide association identifies three new susceptibility loci for Paget's disease of bone
Nature Genetics
2010
-
Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: A meta-analysis
European Heart Journal, Vol. 31, Núm. 17, pp. 2156-2169